Media coverage
1Media coverage
Title Tucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer Media name/outlet Clinical Trials.gov Country United States Date 10/2/18 Persons Andrew Brenner
Press/Media: Press / Media
Media coverage
Title | Tucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer |
---|---|
Media name/outlet | Clinical Trials.gov |
Country | United States |
Date | 10/2/18 |
Persons | Andrew Brenner |